ParaSonic

Company Overview

Snapshot

Founded in January 2014 by Mor Cohen, ParaSonic operates with 1–10 employees. The company has raised $4.98M across 4 funding rounds from 5 investors. In May 2019, ParaSonic secured funding from ExitValley.

Business overview

ParaSonic develops a home-use medical device designed to eliminate lice and their eggs. Its core technology utilizes short, pulsed ultrasound waves generated by a wide-toothed comb, complemented by a natural solution spray, to destroy parasites. The company operates within the Health Tech & Life Sciences sector, specifically focusing on Medical Devices and Medical Treatment & Therapeutics, serving global markets with a B2C and B2B2C business model for consumers, particularly parents and children.

Strategic signal

In May 2019, ParaSonic secured funding from ExitValley, indicating continued investor confidence in its ultrasound-based lice treatment technology. This suggests ongoing validation of its innovative approach within the medical device market, particularly for home-care solutions targeting common health issues.

Company Intelligence Q&A

What is ParaSonic's primary product?

ParaSonic has developed a home-use device that uses short, pulsed ultrasound waves to kill lice and their eggs in a single combing treatment, augmented by a natural solution spray.

When was ParaSonic founded?

ParaSonic was founded in January 2014.

What is the status of ParaSonic?

ParaSonic is currently Non Active, having ceased to operate in August 2025.